User profiles for Peter J. Neumann

Peter J. Neumann

Director, Center for the Evaluation of Value and Risk in Health
Verified email at tuftsmedicalcenter.org
Cited by 30712

Recommendations for conduct, methodological practices, and reporting of cost-effectiveness analyses: second panel on cost-effectiveness in health and medicine

GD Sanders, PJ Neumann, A Basu, DW Brock… - Jama, 2016 - jamanetwork.com
Importance Since publication of the report by the Panel on Cost-Effectiveness in Health and
Medicine in 1996, researchers have advanced the methods of cost-effectiveness analysis, …

[PDF][PDF] Updating cost-effectiveness—the curious resilience of the $50,000-per-QALY threshold

PJ Neumann, JT Cohen, MC Weinstein - N Engl J Med, 2014 - med.unipmn.it
797 ferred a threshold of $200,000 to $300,000 per QALY on the basis of increases in
health care spending over time and the health gains that have been associated with those …

[BOOK][B] Cost-effectiveness in health and medicine

PJ Neumann, GD Sanders, LB Russell, JE Siegel… - 2016 - books.google.com
A COMPLETE UPDATE AND REVISION OF THE CLASSIC TEXT" At last, a manual of
operations for comparing the cost-effectiveness of a preventive service with a treatment …

Preference-based measures in economic evaluation in health care

PJ Neumann, SJ Goldie… - Annual review of public …, 2000 - annualreviews.org
▪ Abstract Estimating preferences for states of health has been an active area of research in
recent years. Unlike psychophysical approaches, which discriminate levels of health status, …

[PDF][PDF] Medicare and cost-effectiveness analysis

PJ Neumann, AB Rosen, MC Weinstein - New England Journal of …, 2005 - gero.usc.edu
The Medicare program has been a notable holdout in the global movement toward the use
of cost-effectiveness analysis to inform health care decisions. Unlike the reimbursement …

Long-term persistence in use of statin therapy in elderly patients

…, H Mogun, PJ Neumann, MC Weinstein, J Avorn - Jama, 2002 - jamanetwork.com
ContextKnowledge of long-term persistence with 3-hydroxy-3-methylglutaryl coenzyme A
reductase inhibitor (statin) therapy is limited because previous studies have observed patients …

Using real‐world data for coverage and payment decisions: the ISPOR real‐world data task force report

LP Garrison Jr, PJ Neumann, P Erickson… - Value in …, 2007 - Wiley Online Library
Objectives: Health decision‐makers involved with coverage and payment policies are
increasingly developing policies that seek information on “real‐world” (RW) outcomes. Motivated …

[HTML][HTML] Does preventive care save money? Health economics and the presidential candidates

JT Cohen, PJ Neumann… - New England Journal of …, 2008 - Mass Medical Soc
A popular component of the candidates' plans for controlling spiraling health care costs
involves greater promotion of preventive health measures. Joshua Cohen, Peter Neumann, and …

Key principles for the improved conduct of health technology assessments for resource allocation decisions

…, B Jönsson, BR Luce, PJ Neumann… - International journal of …, 2008 - cambridge.org
Health technology assessment (HTA) is a dynamic, rapidly evolving process, embracing
different types of assessments that inform real-world decisions about the value (ie, benefits, risks…

Economic impact of childhood and adult attention-deficit/hyperactivity disorder in the United States

…, J Setyawan, MH Erder, PJ Neumann - Journal of the American …, 2012 - Elsevier
OBJECTIVE: Attention-deficit/hyperactivity disorder (ADHD) is one of the most prevalent
mental disorders in children in the United States and often persists into adulthood with …